Presocor may be available in the countries listed below.
Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Presocor in the following countries:
International Drug Name Search
In the US, Slow-Mag (magnesium chloride systemic) is a member of the drug class minerals and electrolytes and is used to treat Heart Attack and Hypomagnesemia.
US matches:
Magnesium Chloride is reported as an ingredient of Slow-Mag in the following countries:
International Drug Name Search
Generic Name: retaplase (RE te plase)
Brand Names: Retavase
Retaplase is a thrombolytic (THROM-bo-LIT-ik) drug that is used to dissolve blood clots.
Retaplase is used to improve heart function and prevent congestive heart failure or death in people who have had a heart attack.
Retaplase may also be used for other purposes not listed in this medication guide.
Before using retaplase, tell your doctor if you have kidney or liver disease, eye complications caused by diabetes, an infection of the lining of your heart, or if you have had any recent surgery, injury, or major bleeding.
Tell your doctor if you take aspirin, a blood thinner such as warfarin (Coumadin), or any medications to prevent blood clots, such as abciximab (ReoPro), dipyridamole (Persantine), and others.
any active bleeding;
a bleeding or blood clotting disorder;
a brain tumor, aneurysm, or blood vessel disorder;
untreated or uncontrolled high blood pressure;
a history of stroke or blood clot; or
recent spine or brain injury or surgery.
Before you receive retaplase, tell your doctor if you are allergic to any drugs, or if you have:
kidney disease;
liver disease;
eye complications caused by diabetes;
an infection of the lining of your heart (also called bacterial endocarditis); or
if you have had any recent surgery, injury, or major bleeding.
If you have any of these conditions, you may need a dose adjustment or special tests to safely receive this medicaiton.
Retaplase is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting.
Retaplase is usually given in two quick injections through an IV line. These injection are given 30 minutes apart.
This medication can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you have received retaplase.
Since retaplase is given only when needed by a healthcare professional, it is not likely that you will miss a dose.
An overdose of retaplase is not likely to occur.
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using retaplase.
sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, problems with vision, speech, or balance;
chest pain, sudden cough, wheezing, rapid breathing;
fast, slow, or uneven heart rate;
feeling like you might pass out;
weak pulse, fainting, slow breathing (breathing may stop);
darkening or purple discoloration of your fingers or toes;
blood in your urine;
black, bloody, or tarry stools;
coughing up blood or vomit that looks like coffee grounds;
bleeding from needle punctures (such as from needles used in blood tests or in giving injection) injections; or
pale skin, easy bruising, or any bleeding that will not stop.
Less serious side effects may include:
nausea;
vomiting; or
fever.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Myocardial Infarction:
10 units administered over 2 minutes as an IV bolus as soon as possible after the onset of acute myocardial infarction (AMI) symptoms, followed 30 minutes later by a second 10 unit IV bolus injection also administered over 2 minutes.
If serious bleeding (not controllable by local pressure) occurs before the administration of the second bolus, terminate any concomitant anticoagulant therapy and do not administer the second reteplase bolus.
Half dose reteplase (5 units) has been used in the GUSTO V trial in combination with abciximab.
The following drugs can interact with retaplase. Tell your doctor if you are using any of these:
a blood thinner such as warfarin (Coumadin);
aspirin; or
medication used to prevent blood clots, such as abciximab (ReoPro), dipyridamole (Persantine), and others.
This list is not complete and there may be other drugs that can interact with retaplase. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
See also: retaplase side effects (in more detail)
Soventol HydroCort may be available in the countries listed below.
Hydrocortisone is reported as an ingredient of Soventol HydroCort in the following countries:
Hydrocortisone 21-acetate (a derivative of Hydrocortisone) is reported as an ingredient of Soventol HydroCort in the following countries:
International Drug Name Search
Sertralina Sandoz may be available in the countries listed below.
Sertraline is reported as an ingredient of Sertralina Sandoz in the following countries:
Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertralina Sandoz in the following countries:
International Drug Name Search
Lipopres may be available in the countries listed below.
Lovastatin is reported as an ingredient of Lipopres in the following countries:
International Drug Name Search
Cesol may be available in the countries listed below.
Praziquantel is reported as an ingredient of Cesol in the following countries:
International Drug Name Search
